Product News

ACCORD HEALTHCARE LAUNCH DARUNAVIR

BNPD20170718A-034_C copy

Accord Healthcare is delighted to announce the launch of Darunavir 800 mg x 30 Film-Coated Tablets.

This medicine co-administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (HIV-1) infection.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free